EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $796,667 | -36.7% | 67,457 | +237.7% | 0.14% | -0.7% |
| Q2 2021 | $1,258,000 | +11.8% | 19,975 | +65.0% | 0.14% | +10.3% |
| Q1 2021 | $1,125,000 | -0.7% | 12,108 | +10.4% | 0.13% | -21.2% |
| Q3 2020 | $1,133,000 | +7.5% | 10,964 | -17.8% | 0.16% | -5.9% |
| Q2 2020 | $1,054,000 | +1.2% | 13,332 | -25.9% | 0.17% | -16.3% |
| Q1 2020 | $1,041,000 | -47.0% | 17,998 | -45.7% | 0.20% | -33.2% |
| Q4 2018 | $1,963,000 | -24.6% | 33,115 | -16.2% | 0.30% | -10.6% |
| Q3 2018 | $2,602,000 | +25.0% | 39,530 | -4.1% | 0.34% | +14.1% |
| Q2 2018 | $2,081,000 | -9.2% | 41,225 | -5.3% | 0.30% | -8.6% |
| Q1 2018 | $2,291,000 | +9.1% | 43,510 | -3.7% | 0.33% | +13.2% |
| Q4 2017 | $2,100,000 | +16.3% | 45,200 | +1.3% | 0.29% | +13.4% |
| Q3 2017 | $1,805,000 | +393.2% | 44,635 | +242.7% | 0.25% | +262.9% |
| Q2 2016 | $366,000 | – | 13,025 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |